Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: The Atherosclerosis Risk in Communities (ARIC) Study

Atherosclerosis

Volumn 200, Issue 2, 2008, Pages 322-328

  Chamberlain, Alanna M ^a   Folsom, Aaron R ^a   Schreiner, Pamela J ^a   Boerwinkle, Eric ^b   Ballantyne, Christie M ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein E; Cholesteryl ester transfer protein; HDL; Hepatic lipase; LDL; Lipoprotein lipase; Menopause

Indexed keywords

APOLIPOPROTEIN E; ARGININE; CHOLESTEROL ESTER TRANSFER PROTEIN; CYSTEINE; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERINE;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; ATHEROSCLEROSIS; CETP GENE; EUROPEAN AMERICAN; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOP CODON;

ALLELES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENOTYPE; HUMANS; LIPASE; LIPOPROTEIN LIPASE; MENOPAUSE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 52049092246     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.045     Document Type: Article

References (30)

1. Rosenson R.S. Low HDL-C: a secondary target of dyslipidemia therapy. Am J Med 118 10 (2005 Oct) 1067-1077
2. Jones P.H. Low-density lipoprotein cholesterol reduction and cardiovascular disease prevention: the search for superior treatment. Am J Med 116 Suppl. 6A (2004 Mar) 17S-25S
3. Lusis A.J. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res 29 4 (1988 Apr) 397-429
4. Masson L.F., and McNeill G. The effect of genetic variation on the lipid response to dietary change: recent findings. Curr Opin Lipidol 16 1 (2005 Feb) 61-67
5. Middelberg R.P., Spector T.D., Swaminathan R., and Snieder H. Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol 22 7 (2002 Jul) 1142-1147
6. Lewis-Barned N.J., Sutherland W.H., Walker R.J., et al. Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women. J Clin Endocrinol Metab 84 10 (1999 Oct) 3534-3538
7. Schaefer E.J., Lamon-Fava S., Cohn S.D., et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 35 5 (1994 May) 779-792
8. Guthrie J.R., Taffe J.R., Lehert P., Burger H.G., and Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 11 3 (2004 May-Jun) 315-322
9. Davignon J., Cohn J.S., Mabile L., and Bernier L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 286 1-2 (1999) 115-143
10. Foley S.M. Update on risk factors for atherosclerosis: the role of inflammation and apolipoprotein E. Medsurg Nurs 14 1 (2005 Feb) 43-50
11. Schaefer E.J., Lamon-Fava S., Johnson S., et al. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler Thromb 14 7 (1994 Jul) 1105-1113
12. Tall A. Plasma cholesteryl ester transfer protein. J Lipid Res 34 8 (1993 August) 1255-1274
13. Bernard S., Moulin P., Lagrost L., et al. Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. J Lipid Res 39 1 (1998 Jan) 59-65
14. Perret B., Mabile L., Martinez L., et al. Hepatic lipase: structure/function relationship, synthesis, and regulation. J Lipid Res 43 8 (2002 Aug) 1163-1169
15. Yamakawa-Kobayashi K., Somekawa Y., Fujimura M., et al. Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy. Atherosclerosis 162 1 (2002 May) 17-21
16. Goldberg I.J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37 4 (1996 Apr) 693-707
17. Lopez-Miranda J., Cruz G., Gomez P., et al. The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism. J Clin Endocrinol Metab 89 9 (2004 Sep) 4721-4728
18. Brousseau M.E., Goldkamp A.L., Collins D., et al. Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial. J Lipid Res 45 10 (2004 Oct) 1885-1891
19. Sultan N., Nawaz M., Sultan A., Fayaz M., and Baseer A. Effect of menopause on serum HDL-cholesterol level. J Ayub Med Coll, Abbottabad (JAMC) 15 3 (2003 Jul-Sep) 24-26
20. Brinton E.A. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 16 3 (1996 March) 431-440
21. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989 Apr;129(4):687-702.
22. Papp A.C., Hatzakis H., Bracey A., and Wu K.K. ARIC hemostasis study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 61 1 (1989 Feb) 15-19
23. Siedel J., Hagele E., Ziegenhorn J., and Wahlefeld A. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29 6 (1983 June) 1075-1080
24. Nagele U., Hagele E.O., Sauer G., et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 22 2 (1984 Feb) 165-174
25. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28 6 (1982 Jun) 1379-1388
26. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 6 (1972 June) 499-502
27. Chambless L.E., McMahon R.P., Brown S.A., et al. Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 136 9 (1992 Nov) 1069-1081
28. Boekholdt S.M., and Thompson J.F. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res 44 6 (2003 July) 1080-1093
29. Rip J., Nierman M.C., Ross C.J., et al. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol 26 6 (2006 June) 1236-1245
30. Wittrup H.H., Tybjaerg-Hansen A., and Nordestgaard B.G. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99 22 (1999 Jun) 2901-2907